that specifically targets the alpha(5)beta(1) integrin which is over-expressed in a variety of cancer cells and on tumor vasculature
Story Title | Content type | Authored by | Authored on |
---|---|---|---|
Bioengineering Seminar Series | Event | Colly Mitchell |
Tuesday, April 29, 2025
Story Title | Content type | Authored by | Authored on |
---|---|---|---|
Bioengineering Seminar Series | Event | Colly Mitchell |